Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serena Ruggieri

Showing results (51-60 of 104) with videos related to

Pageof 11
Sort By:
Journal of the Neurological Sciences|March 4, 2026
Predictors of short-term, relapse-independent progression in multiple sclerosis: A machine learning approach based on clinical data and conventional MRI-derived featuresAntonio Ianniello, Elena Barbuti, Maria Francesca Capobianco, et al.
Medicina (Kaunas, Lithuania)|March 29, 2023
Potential Protective Role of Pregnancy and Breastfeeding in Delaying Onset Symptoms Related to Multiple SclerosisAlessandra Logoteta, Maria Grazia Piccioni, Riccardo Nistri, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 29, 2025
Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched studyElena Barbuti, Alessia Castiello, Valeria Pozzilli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 25, 2020
Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosisLuca Prosperini, Chiara Mancinelli, Shalom Haggiag, et al.
Immunology Letters|January 14, 2014
CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytesCristina Camperio, Michela Muscolini, Elisabetta Volpe, et al.
Scientific Reports|March 1, 2018
FoxP3 isoforms and PD-1 expression by T regulatory cells in multiple sclerosisManolo Sambucci, Francesca Gargano, Veronica De Rosa, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 21, 2020
EBV-specific CD8 T lymphocytes and B cells during glatiramer acetate therapy in patients with MSGisella Guerrera, Serena Ruggieri, Mario Picozza, et al.
International Journal of Molecular Sciences|December 6, 2016
Dysregulated Homeostasis of Acetylcholine Levels in Immune Cells of RR-Multiple Sclerosis PatientsMaria Di Bari, Marcella Reale, Marta Di Nicola, et al.
Neurology International|August 27, 2025
Characterization of QuantiFERON-TB-Plus Results in Patients with Tuberculosis Infection and Multiple SclerosisElisa Petruccioli, Luca Prosperini, Serena Ruggieri, et al.
Multiple Sclerosis and Related Disorders|September 19, 2024
Neurophysiological methods for assessing and treating cognitive impairment in multiple sclerosis: A scoping review of the literatureAlessandro Cruciani, Francesca Santoro, Valeria Pozzilli, et al.
Pageof 11

Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
Journal of the Neurological Sciences|March 4, 2026
Predictors of short-term, relapse-independent progression in multiple sclerosis: A machine learning approach based on clinical data and conventional MRI-derived featuresAntonio Ianniello, Elena Barbuti, Maria Francesca Capobianco, et al.
Medicina (Kaunas, Lithuania)|March 29, 2023
Potential Protective Role of Pregnancy and Breastfeeding in Delaying Onset Symptoms Related to Multiple SclerosisAlessandra Logoteta, Maria Grazia Piccioni, Riccardo Nistri, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 29, 2025
Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched studyElena Barbuti, Alessia Castiello, Valeria Pozzilli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 25, 2020
Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosisLuca Prosperini, Chiara Mancinelli, Shalom Haggiag, et al.
Immunology Letters|January 14, 2014
CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytesCristina Camperio, Michela Muscolini, Elisabetta Volpe, et al.
Scientific Reports|March 1, 2018
FoxP3 isoforms and PD-1 expression by T regulatory cells in multiple sclerosisManolo Sambucci, Francesca Gargano, Veronica De Rosa, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 21, 2020
EBV-specific CD8 T lymphocytes and B cells during glatiramer acetate therapy in patients with MSGisella Guerrera, Serena Ruggieri, Mario Picozza, et al.
International Journal of Molecular Sciences|December 6, 2016
Dysregulated Homeostasis of Acetylcholine Levels in Immune Cells of RR-Multiple Sclerosis PatientsMaria Di Bari, Marcella Reale, Marta Di Nicola, et al.
Neurology International|August 27, 2025
Characterization of QuantiFERON-TB-Plus Results in Patients with Tuberculosis Infection and Multiple SclerosisElisa Petruccioli, Luca Prosperini, Serena Ruggieri, et al.
Multiple Sclerosis and Related Disorders|September 19, 2024
Neurophysiological methods for assessing and treating cognitive impairment in multiple sclerosis: A scoping review of the literatureAlessandro Cruciani, Francesca Santoro, Valeria Pozzilli, et al.
Pageof 11